Acadian Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,680	Closed	-$62K	–	1631
2024 Q3	$62K	Sell	6,680 -153,348	-96%	-$1.42M	﹤0.01%	1743
2024 Q2	$1.49M	Buy	+160,028	New	+$1.49M	﹤0.01%	868
2024 Q1	–	Sell	-354,112	Closed	-$1.14M	–	1562
2023 Q4	$1.14M	Buy	+354,112	New	+$1.14M	﹤0.01%	823